Literature DB >> 2869807

Hypersensitivity to methoxamine in atria isolated from streptozotocin-induced diabetic rats.

L Canga, L Sterin-Borda.   

Abstract

The reactivity to methoxamine (Met) of atria isolated from the hearts of normal and from acutely streptozotocin-diabetic rats has been studied. Met (1 X 10(-6) M) increased the tension of both normal and diabetic atria, but in diabetic atria, the dose-response curve to Met was shifted to the left and the efficacy of Met was enhanced. Inhibitors of alpha-adrenoceptors blocked, in a competitive manner, the positive inotropic effect induced by Met in both types of atrial preparations. Inhibitors of the cyclo-oxygenase pathway for arachidonic acid metabolism blocked the atrial response to Met in non-diabetic as well as in diabetic atria. The inhibition of prostacyclin synthetase prevented the effect of Met in normal atria, while blockers of thromboxane generation inhibited it in diabetic ones. Agents that inhibit the activity of lipoxygenase(s) significantly reduced the positive inotropic action induced by Met in diabetic atria but failed to modify it in non-diabetic preparations. These results show that diabetic atria are more sensitive to Met than normal atria. In diabetes the response to alpha-adrenoceptor stimulation could be mediated by oxidative product generated via thromboxane synthetase and lipoxygenase(s) activities; whereas in normal preparations the action of Met may involve the release of prostacyclin.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2869807      PMCID: PMC1916884          DOI: 10.1111/j.1476-5381.1986.tb10167.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  29 in total

1.  Cumulative dose-response curves. II. Technique for the making of dose-response curves in isolated organs and the evaluation of drug parameters.

Authors:  J M VAN ROSSUM
Journal:  Arch Int Pharmacodyn Ther       Date:  1963

2.  On the presence and distribution of alpha-adrenoceptors in the heart of various mammalian species.

Authors:  J Wagner; O E Brodde
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1978-05       Impact factor: 3.000

3.  Demonstration in human atrial preparations of alpha-adrenoceptors mediating positive inotropic effects.

Authors:  H J Schümann; J Wagner; A Knorr; J C Reidemeister; V Sadony; G Schramm
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1978-05       Impact factor: 3.000

Review 4.  Unstable metabolites of arachidonic acid and their role in haemostasis and thrombosis.

Authors:  S Moncada; J R Vane
Journal:  Br Med Bull       Date:  1978-05       Impact factor: 4.291

5.  Characterization of -adrenoceptors in the myocardium.

Authors:  B G Benfey
Journal:  Br J Pharmacol       Date:  1973-05       Impact factor: 8.739

6.  Stimulant action of methoxamine in the isolated atria of normal and 6-propyl-2-thiouracil-fed rats.

Authors:  M Nakashima; H Tsuru; T Shigei
Journal:  Jpn J Pharmacol       Date:  1973-06

7.  Arterial walls are protected against deposition of platelet thrombi by a substance (prostaglandin X) which they make from prostaglandin endoperoxides.

Authors:  R J Gryglewski; S Bunting; S Moncada; R J Flower; J R Vane
Journal:  Prostaglandins       Date:  1976-11

8.  The positive inotropic effect of sodium arachidonate on auricles from diabetic rats.

Authors:  L Canga; L Sterin-Borda; E S Borda; H Peredo; A L Gimeno
Journal:  Eur J Pharmacol       Date:  1985-03-26       Impact factor: 4.432

9.  Effect of experimental diabetes, food deprivation and genetic obesity on the sensitivity of pithed rats to autonomic agents.

Authors:  J M Foy; P D Lucas
Journal:  Br J Pharmacol       Date:  1976-06       Impact factor: 8.739

10.  Imidazole: a selective inhibitor of thromboxane synthetase.

Authors:  S Moncada; S Bunting; K Mullane; P Thorogood; J R Vane; A Raz; P Needleman
Journal:  Prostaglandins       Date:  1977-04
View more
  1 in total

1.  Alterations in atrial reactivity in a strain of spontaneously diabetic rats.

Authors:  W Durante; F A Sunahara; A K Sen
Journal:  Br J Pharmacol       Date:  1989-08       Impact factor: 8.739

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.